Trastuzumab deruxtecan in the treatment of adult patients with HER-positive breast cancer

被引：0
|
作者：
Krzakowski, Maciej [1 ]
机构：
[1] Natl Oncol Inst Mar Sklodowska Curie, Natl Res Inst, Dept Lung & Chest Canc, Warsaw, Poland
来源：
ONCOLOGY IN CLINICAL PRACTICE | 2023年 / 19卷 / 05期
关键词：
D O I：
10.5603/ocp.97613
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：382 / 383
页数：2
相关论文
共 50 条
  • [31] Trastuzumab Deruxtecan for HER2-Positive Breast Cancer with Central Nervous System Metastasis
    Yamane, Hiroaki
    Itagaki, Tomoko
    Kajitani, Keiko
    CASE REPORTS IN ONCOLOGY, 2025, 18 (01): : 22 - 28
  • [32] Trastuzumab deruxtecan: Defining a novel systemic treatment standard for HER2-positive breast cancer brain metastases?
    Bartsch, Rupert
    Preusser, Matthias
    NEURO-ONCOLOGY, 2024, 26 (12) : 2157 - 2158
  • [33] A randomized trial of trastuzumab deruxtecan and biologydriven selection of neoadjuvant treatment for HER2-positive breast cancer (ARIADNE)
    Foukakis, T.
    Naume, B.
    Karakatsanis, A.
    Andersson, A.
    Barnekow, E.
    Kessler, L. Edman
    Einbeigi, Z.
    Engebraten, O.
    Killander, F.
    Linderholm, B. K.
    Schiza, A.
    Valachis, A.
    Bergh, J.
    Villacampa, G.
    Zouzos, A.
    Hellstrom, M.
    Hartman, J.
    Matikas, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S356 - S356
  • [34] Real World Data for Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases
    Toler, Andrew
    Bobolts, Laura R.
    Mangurian, Mark
    Pozotrigo, Melissa
    Wise, Corey
    Solomon, Hiywete
    Hartung, Nicole
    Makielski, Rory
    Marur, Shika
    Ravindranathan, Meera
    Marur, Shanthi
    CANCER RESEARCH, 2023, 83 (05)
  • [35] Cost-effectiveness analysis of trastuzumab deruxtecan versus trastuzumab emtansine for HER2-positive breast cancer
    Yang, Jiangping
    Han, Jiaqi
    Zhang, Yalan
    Muhetaer, Muhelisa
    Chen, Nianyong
    Yan, Xi
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [36] Safety and efficacy of trastuzumab deruxtecan and concomitant radiation therapy in patients with metastatic HER2-positive breast cancer
    Becherini, Carlotta
    Bertini, Niccolo'
    Bonaparte, Ilaria
    Burchini, Luca
    Orsatti, Carolina
    Valzano, Marianna
    Banini, Marco
    Salvestrini, Viola
    Scoccimarro, Erika
    Scotti, Vieri
    Desideri, Isacco
    Francolini, Giulio
    Orzalesi, Lorenzo
    Bernini, Marco
    Tommasi, Cinzia
    Nori, Jacopo
    Bianchi, Simonetta
    Meattini, Icro
    Livi, Lorenzo
    CANCER RESEARCH, 2024, 84 (09)
  • [37] Trastuzumab deruxtecan for the treatment of HER2-positive advanced gastric cancer: a clinical perspective
    Masahiko Aoki
    Satoru Iwasa
    Narikazu Boku
    Gastric Cancer, 2021, 24 : 567 - 576
  • [38] Trastuzumab Deruxtecan for Breast Cancer
    Zheng, Fangchao
    Du, Feng
    Yuan, Peng
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (24): : 2346 - 2347
  • [39] Trastuzumab deruxtecan for the treatment of HER2-positive advanced gastric cancer: a clinical perspective
    Aoki, Masahiko
    Iwasa, Satoru
    Boku, Narikazu
    GASTRIC CANCER, 2021, 24 (03) : 567 - 576
  • [40] TRASTUZUMAB DERUXTECAN IS EFFECTIVE IN HER2-LOW BREAST CANCER
    不详
    CANCER DISCOVERY, 2020, 10 (04) : 488 - 488
12345